<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Gout Quick Reference - Clinical Tool</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        :root {
            --red-urgent: #dc2626;
            --red-light: #fef2f2;
            --red-border: #fecaca;
            --green-safe: #16a34a;
            --green-light: #f0fdf4;
            --green-border: #bbf7d0;
            --blue-info: #2563eb;
            --blue-light: #eff6ff;
            --blue-border: #bfdbfe;
            --gray-50: #f9fafb;
            --gray-100: #f3f4f6;
            --gray-200: #e5e7eb;
            --gray-300: #d1d5db;
            --gray-600: #4b5563;
            --gray-700: #374151;
            --gray-800: #1f2937;
            --shadow: 0 1px 3px rgba(0,0,0,0.1), 0 1px 2px rgba(0,0,0,0.06);
            --shadow-md: 0 4px 6px rgba(0,0,0,0.1), 0 2px 4px rgba(0,0,0,0.06);
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            background: var(--gray-100);
            color: var(--gray-800);
            line-height: 1.5;
            padding: 1rem;
        }

        .header {
            background: linear-gradient(135deg, #1e40af 0%, #3b82f6 100%);
            color: white;
            padding: 1rem 1.5rem;
            border-radius: 12px;
            margin-bottom: 1rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
            flex-wrap: wrap;
            gap: 1rem;
        }

        .header h1 {
            font-size: 1.5rem;
            font-weight: 700;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .header-meta {
            font-size: 0.875rem;
            opacity: 0.9;
        }

        .nav-tabs {
            display: flex;
            gap: 0.5rem;
            margin-bottom: 1rem;
            flex-wrap: wrap;
        }

        .nav-tab {
            padding: 0.5rem 1rem;
            background: white;
            border: 2px solid var(--gray-200);
            border-radius: 8px;
            cursor: pointer;
            font-weight: 500;
            transition: all 0.2s ease;
            font-size: 0.875rem;
        }

        .nav-tab:hover {
            border-color: var(--blue-info);
            background: var(--blue-light);
        }

        .nav-tab.active {
            background: var(--blue-info);
            color: white;
            border-color: var(--blue-info);
        }

        .nav-tab.urgent {
            border-color: var(--red-border);
        }

        .nav-tab.urgent:hover, .nav-tab.urgent.active {
            background: var(--red-urgent);
            border-color: var(--red-urgent);
            color: white;
        }

        .content-section {
            display: none;
            animation: fadeIn 0.3s ease;
        }

        .content-section.active {
            display: block;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .two-column {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 1rem;
        }

        @media (max-width: 900px) {
            .two-column {
                grid-template-columns: 1fr;
            }
        }

        .card {
            background: white;
            border-radius: 12px;
            box-shadow: var(--shadow);
            overflow: hidden;
            transition: box-shadow 0.2s ease, transform 0.2s ease;
        }

        .card:hover {
            box-shadow: var(--shadow-md);
            transform: translateY(-2px);
        }

        .card-header {
            padding: 0.75rem 1rem;
            font-weight: 600;
            display: flex;
            align-items: center;
            gap: 0.5rem;
            font-size: 0.95rem;
        }

        .card-header.urgent {
            background: var(--red-urgent);
            color: white;
        }

        .card-header.safe {
            background: var(--green-safe);
            color: white;
        }

        .card-header.info {
            background: var(--blue-info);
            color: white;
        }

        .card-header.neutral {
            background: var(--gray-700);
            color: white;
        }

        .card-body {
            padding: 1rem;
        }

        .alert-banner {
            padding: 1rem;
            border-radius: 8px;
            margin-bottom: 1rem;
            display: flex;
            align-items: flex-start;
            gap: 0.75rem;
            animation: pulse 2s infinite;
        }

        @keyframes pulse {
            0%, 100% { opacity: 1; }
            50% { opacity: 0.85; }
        }

        .alert-banner.urgent {
            background: var(--red-light);
            border: 2px solid var(--red-urgent);
            color: var(--red-urgent);
        }

        .alert-banner .icon {
            font-size: 1.5rem;
            flex-shrink: 0;
        }

        .alert-banner h3 {
            font-weight: 700;
            margin-bottom: 0.25rem;
        }

        ul.checklist {
            list-style: none;
            padding: 0;
        }

        ul.checklist li {
            padding: 0.5rem 0;
            padding-left: 1.75rem;
            position: relative;
            border-bottom: 1px solid var(--gray-100);
            transition: background 0.2s ease;
        }

        ul.checklist li:hover {
            background: var(--gray-50);
        }

        ul.checklist li:last-child {
            border-bottom: none;
        }

        ul.checklist li::before {
            content: "‚Ä¢";
            position: absolute;
            left: 0.5rem;
            color: var(--gray-400);
            font-weight: bold;
        }

        ul.checklist.urgent li::before {
            content: "‚ö†";
            color: var(--red-urgent);
        }

        ul.checklist.safe li::before {
            content: "‚úì";
            color: var(--green-safe);
        }

        ul.checklist.info li::before {
            content: "‚Ñπ";
            color: var(--blue-info);
        }

        .highlight-box {
            padding: 0.75rem 1rem;
            border-radius: 8px;
            margin: 0.5rem 0;
        }

        .highlight-box.urgent {
            background: var(--red-light);
            border-left: 4px solid var(--red-urgent);
        }

        .highlight-box.safe {
            background: var(--green-light);
            border-left: 4px solid var(--green-safe);
        }

        .highlight-box.info {
            background: var(--blue-light);
            border-left: 4px solid var(--blue-info);
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 0.875rem;
        }

        th, td {
            padding: 0.75rem;
            text-align: left;
            border-bottom: 1px solid var(--gray-200);
        }

        th {
            background: var(--gray-50);
            font-weight: 600;
        }

        tr:hover {
            background: var(--gray-50);
        }

        .dose-table td:first-child {
            font-weight: 500;
            color: var(--blue-info);
        }

        .tag {
            display: inline-block;
            padding: 0.25rem 0.5rem;
            border-radius: 4px;
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
        }

        .tag.first-line {
            background: var(--green-light);
            color: var(--green-safe);
        }

        .tag.second-line {
            background: var(--blue-light);
            color: var(--blue-info);
        }

        .tag.caution {
            background: #fef3c7;
            color: #d97706;
        }

        .tag.contraindicated {
            background: var(--red-light);
            color: var(--red-urgent);
        }

        .quick-action {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            padding: 0.75rem;
            background: var(--gray-50);
            border-radius: 8px;
            margin: 0.5rem 0;
            transition: all 0.2s ease;
            cursor: pointer;
        }

        .quick-action:hover {
            background: var(--gray-100);
            transform: translateX(4px);
        }

        .quick-action .action-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.25rem;
            flex-shrink: 0;
        }

        .quick-action .action-icon.urgent {
            background: var(--red-light);
        }

        .quick-action .action-icon.safe {
            background: var(--green-light);
        }

        .quick-action .action-icon.info {
            background: var(--blue-light);
        }

        .quick-action-content {
            flex: 1;
        }

        .quick-action-title {
            font-weight: 600;
            font-size: 0.9rem;
        }

        .quick-action-desc {
            font-size: 0.8rem;
            color: var(--gray-600);
        }

        .target-value {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            padding: 0.5rem 1rem;
            background: var(--green-light);
            border: 2px solid var(--green-safe);
            border-radius: 8px;
            font-weight: 600;
            color: var(--green-safe);
        }

        .target-value.secondary {
            background: var(--blue-light);
            border-color: var(--blue-info);
            color: var(--blue-info);
        }

        .criteria-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(200px, 1fr));
            gap: 0.5rem;
        }

        .criteria-item {
            padding: 0.5rem 0.75rem;
            background: var(--gray-50);
            border-radius: 6px;
            font-size: 0.85rem;
            display: flex;
            align-items: center;
            gap: 0.5rem;
            transition: all 0.2s ease;
        }

        .criteria-item:hover {
            background: var(--blue-light);
        }

        .criteria-item .check {
            color: var(--green-safe);
        }

        .flow-step {
            display: flex;
            align-items: flex-start;
            gap: 1rem;
            padding: 1rem 0;
            border-bottom: 1px dashed var(--gray-200);
        }

        .flow-step:last-child {
            border-bottom: none;
        }

        .step-number {
            width: 32px;
            height: 32px;
            border-radius: 50%;
            background: var(--blue-info);
            color: white;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 700;
            flex-shrink: 0;
        }

        .step-content {
            flex: 1;
        }

        .step-title {
            font-weight: 600;
            margin-bottom: 0.25rem;
        }

        .step-desc {
            font-size: 0.875rem;
            color: var(--gray-600);
        }

        .drug-card {
            border: 1px solid var(--gray-200);
            border-radius: 8px;
            margin-bottom: 0.75rem;
            overflow: hidden;
        }

        .drug-header {
            padding: 0.75rem 1rem;
            background: var(--gray-50);
            display: flex;
            justify-content: space-between;
            align-items: center;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .drug-header:hover {
            background: var(--gray-100);
        }

        .drug-name {
            font-weight: 600;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .drug-details {
            padding: 1rem;
            display: none;
            border-top: 1px solid var(--gray-200);
        }

        .drug-details.open {
            display: block;
            animation: slideDown 0.3s ease;
        }

        @keyframes slideDown {
            from { opacity: 0; max-height: 0; }
            to { opacity: 1; max-height: 500px; }
        }

        .footer {
            margin-top: 1.5rem;
            padding: 1rem;
            background: white;
            border-radius: 8px;
            text-align: center;
            font-size: 0.8rem;
            color: var(--gray-600);
        }

        .search-box {
            padding: 0.5rem 1rem;
            border: 2px solid var(--gray-200);
            border-radius: 8px;
            font-size: 0.875rem;
            width: 250px;
            transition: border-color 0.2s ease;
        }

        .search-box:focus {
            outline: none;
            border-color: var(--blue-info);
        }

        .three-column {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 1rem;
        }

        @media (max-width: 1100px) {
            .three-column {
                grid-template-columns: 1fr 1fr;
            }
        }

        @media (max-width: 700px) {
            .three-column {
                grid-template-columns: 1fr;
            }
        }

        .icon-text {
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }
    </style>
</head>
<body>
    <header class="header">
        <h1>
            <span>üíä</span>
            Gout Quick Reference
        </h1>
        <div class="header-meta">
            Based on NICE CKS | Last revised: June 2023 | Adults ‚â•16 years
        </div>
    </header>

    <nav class="nav-tabs">
        <button class="nav-tab urgent active" data-tab="emergency">‚ö†Ô∏è Red Flags</button>
        <button class="nav-tab" data-tab="diagnosis">üîç Diagnosis</button>
        <button class="nav-tab" data-tab="acute">‚ö° Acute Mx</button>
        <button class="nav-tab" data-tab="prevention">üõ°Ô∏è Prevention</button>
        <button class="nav-tab" data-tab="drugs">üíä Prescribing</button>
        <button class="nav-tab" data-tab="referral">üè• Referral</button>
    </nav>

    <!-- RED FLAGS / EMERGENCY SECTION -->
    <section id="emergency" class="content-section active">
        <div class="alert-banner urgent">
            <span class="icon">üö®</span>
            <div>
                <h3>SEPTIC ARTHRITIS - EMERGENCY REFERRAL</h3>
                <p>Hot, swollen joint + systemically unwell (¬± fever) ‚Üí <strong>Immediate referral</strong> for joint aspiration & culture</p>
            </div>
        </div>

        <div class="two-column">
            <div class="card">
                <div class="card-header urgent">
                    ‚ö†Ô∏è Suspect Septic Arthritis If
                </div>
                <div class="card-body">
                    <ul class="checklist urgent">
                        <li>Systemically unwell (with or without fever)</li>
                        <li>Acutely painful, hot, swollen joint</li>
                        <li>Unable to bear weight</li>
                        <li>Recent surgery or joint injection</li>
                        <li>Immunocompromised patient</li>
                        <li>Rapidly worsening symptoms</li>
                    </ul>
                    <div class="highlight-box urgent">
                        <strong>Action:</strong> Do NOT delay - refer immediately via local care pathway
                    </div>
                </div>
            </div>

            <div class="card">
                <div class="card-header urgent">
                    üî¥ Drug Safety Alerts
                </div>
                <div class="card-body">
                    <div class="highlight-box urgent">
                        <strong>COLCHICINE:</strong> Extremely toxic in overdose. Narrow therapeutic window. Max 6mg per course.
                    </div>
                    <div class="highlight-box urgent">
                        <strong>FEBUXOSTAT:</strong> Caution in major CVD (MI, stroke, unstable angina). Offer allopurinol first-line in these patients.
                    </div>
                    <div class="highlight-box urgent">
                        <strong>ALLOPURINOL:</strong> Screen for HLA-B*5801 in Han Chinese, Thai, Korean populations (SJS/TEN risk). Stop immediately if rash develops.
                    </div>
                </div>
            </div>
        </div>

        <div class="card" style="margin-top: 1rem;">
            <div class="card-header neutral">
                ‚ÑπÔ∏è Key Differentials to Consider
            </div>
            <div class="card-body">
                <div class="criteria-grid">
                    <div class="criteria-item">ü¶† Septic arthritis</div>
                    <div class="criteria-item">üíé Pseudogout (CPPD)</div>
                    <div class="criteria-item">üî• Cellulitis</div>
                    <div class="criteria-item">ü¶¥ Osteoarthritis</div>
                    <div class="criteria-item">üîó Rheumatoid arthritis</div>
                    <div class="criteria-item">‚ö° Reactive arthritis</div>
                    <div class="criteria-item">ü©π Trauma</div>
                    <div class="criteria-item">üíº Bursitis</div>
                </div>
            </div>
        </div>
    </section>

    <!-- DIAGNOSIS SECTION -->
    <section id="diagnosis" class="content-section">
        <div class="two-column">
            <div class="card">
                <div class="card-header info">
                    üîç When to Suspect Gout
                </div>
                <div class="card-body">
                    <div class="highlight-box safe">
                        <strong>Classic Presentation:</strong> Rapid onset (often overnight) of severe pain, redness, swelling in 1st MTP joint
                    </div>
                    <ul class="checklist info">
                        <li><strong>1st MTP joint</strong> - affected in 50% initial attacks, 70% at some point</li>
                        <li>Midfoot, ankle, knee, fingers, wrist, elbow</li>
                        <li>Maximum intensity within 24 hours</li>
                        <li>Usually monoarticular</li>
                        <li>Tophi - firm white nodules (suggests longstanding disease)</li>
                    </ul>
                </div>
            </div>

            <div class="card">
                <div class="card-header info">
                    üß™ Investigations
                </div>
                <div class="card-body">
                    <div class="flow-step">
                        <div class="step-number">1</div>
                        <div class="step-content">
                            <div class="step-title">Serum Urate Level</div>
                            <div class="step-desc">
                                <span class="target-value">‚â•360 ¬µmol/L confirms diagnosis</span>
                                <p style="margin-top: 0.5rem; font-size: 0.85rem;">Note: Gout can occur with normal urate; hyperuricaemia alone doesn't confirm gout</p>
                            </div>
                        </div>
                    </div>
                    <div class="flow-step">
                        <div class="step-number">2</div>
                        <div class="step-content">
                            <div class="step-title">If &lt;360 ¬µmol/L but strongly suspected</div>
                            <div class="step-desc">Repeat 2-4 weeks after flare settles</div>
                        </div>
                    </div>
                    <div class="flow-step">
                        <div class="step-number">3</div>
                        <div class="step-content">
                            <div class="step-title">If diagnosis uncertain</div>
                            <div class="step-desc">Refer for: Joint aspiration & microscopy, Imaging (X-ray, US, dual-energy CT)</div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <div class="card" style="margin-top: 1rem;">
            <div class="card-header neutral">
                üìã ACR Diagnostic Criteria (6+ of 11 confirms gout)
            </div>
            <div class="card-body">
                <div class="criteria-grid">
                    <div class="criteria-item"><span class="check">‚òê</span> &gt;1 attack of acute arthritis</div>
                    <div class="criteria-item"><span class="check">‚òê</span> Max inflammation &lt;1 day</div>
                    <div class="criteria-item"><span class="check">‚òê</span> Monoarthritis attack</div>
                    <div class="criteria-item"><span class="check">‚òê</span> Redness over joint</div>
                    <div class="criteria-item"><span class="check">‚òê</span> 1st MTP painful/swollen</div>
                    <div class="criteria-item"><span class="check">‚òê</span> Unilateral 1st MTP attack</div>
                    <div class="criteria-item"><span class="check">‚òê</span> Unilateral tarsal attack</div>
                    <div class="criteria-item"><span class="check">‚òê</span> Tophus (confirmed/suspected)</div>
                    <div class="criteria-item"><span class="check">‚òê</span> Hyperuricaemia</div>
                    <div class="criteria-item"><span class="check">‚òê</span> Asymmetric joint swelling (X-ray)</div>
                    <div class="criteria-item"><span class="check">‚òê</span> Subcortical cyst, no erosion (X-ray)</div>
                    <div class="criteria-item"><span class="check">‚òê</span> Joint culture negative</div>
                </div>
            </div>
        </div>

        <div class="card" style="margin-top: 1rem;">
            <div class="card-header info">
                üìä Risk Factors
            </div>
            <div class="card-body">
                <div class="two-column">
                    <div>
                        <strong>Patient Factors:</strong>
                        <ul class="checklist">
                            <li>Male sex</li>
                            <li>Older age</li>
                            <li>Postmenopausal women</li>
                            <li>Family history</li>
                            <li>Obesity</li>
                        </ul>
                    </div>
                    <div>
                        <strong>Comorbidities & Drugs:</strong>
                        <ul class="checklist">
                            <li>CKD, hypertension, diabetes, dyslipidaemia</li>
                            <li>Diuretics, low-dose aspirin, ciclosporin</li>
                            <li>Alcohol, sugary drinks, meat, seafood</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- ACUTE MANAGEMENT SECTION -->
    <section id="acute" class="content-section">
        <div class="highlight-box safe" style="margin-bottom: 1rem;">
            <strong>Key Principle:</strong> Treat as soon as possible. Continue any existing ULT during flares.
        </div>

        <div class="two-column">
            <div class="card">
                <div class="card-header safe">
                    ‚úÖ First-Line Treatment Options
                </div>
                <div class="card-body">
                    <p style="margin-bottom: 0.75rem; font-size: 0.9rem; color: var(--gray-600);">Choose based on patient preferences, comorbidities & concurrent medication:</p>
                    
                    <div class="quick-action">
                        <div class="action-icon safe">üíä</div>
                        <div class="quick-action-content">
                            <div class="quick-action-title">NSAID (e.g., Naproxen)</div>
                            <div class="quick-action-desc">Max dose until 1-2 days after attack resolves. Consider PPI cover.</div>
                        </div>
                        <span class="tag first-line">1st Line</span>
                    </div>

                    <div class="quick-action">
                        <div class="action-icon safe">üíä</div>
                        <div class="quick-action-content">
                            <div class="quick-action-title">Colchicine</div>
                            <div class="quick-action-desc">500mcg 2-4√ó daily. Max 6mg per course. Do not repeat within 3 days.</div>
                        </div>
                        <span class="tag first-line">1st Line</span>
                    </div>

                    <div class="quick-action">
                        <div class="action-icon safe">üíä</div>
                        <div class="quick-action-content">
                            <div class="quick-action-title">Prednisolone</div>
                            <div class="quick-action-desc">30-35mg once daily for 3-5 days (off-label)</div>
                        </div>
                        <span class="tag first-line">1st Line</span>
                    </div>

                    <div class="quick-action">
                        <div class="action-icon info">üíâ</div>
                        <div class="quick-action-content">
                            <div class="quick-action-title">IA/IM Corticosteroid</div>
                            <div class="quick-action-desc">If NSAIDs & colchicine not tolerated/ineffective (off-label)</div>
                        </div>
                        <span class="tag second-line">2nd Line</span>
                    </div>
                </div>
            </div>

            <div class="card">
                <div class="card-header info">
                    ‚ÑπÔ∏è Supportive Care & Advice
                </div>
                <div class="card-body">
                    <ul class="checklist safe">
                        <li>Rest and elevate the limb</li>
                        <li>Keep joint exposed and cool</li>
                        <li>Ice pack (helps alleviate pain)</li>
                        <li>Bed-cage if needed</li>
                        <li>Paracetamol as adjunct analgesia</li>
                    </ul>
                    
                    <div class="highlight-box info" style="margin-top: 1rem;">
                        <strong>Return if:</strong> Symptoms worsen OR no improvement after 1-2 days
                    </div>

                    <div class="highlight-box urgent" style="margin-top: 0.5rem;">
                        <strong>Do NOT:</strong> Use aspirin for gout. Do NOT stop existing ULT during flare.
                    </div>
                </div>
            </div>
        </div>

        <div class="card" style="margin-top: 1rem;">
            <div class="card-header neutral">
                üìÖ Follow-Up (4-6 weeks after flare settles)
            </div>
            <div class="card-body">
                <div class="criteria-grid">
                    <div class="criteria-item">üß™ Check serum urate</div>
                    <div class="criteria-item">üìä Assess CV risk factors</div>
                    <div class="criteria-item">ü´ò Check eGFR & ACR (screen CKD)</div>
                    <div class="criteria-item">üíä Review medications</div>
                    <div class="criteria-item">üìã Discuss ULT benefits/risks</div>
                    <div class="criteria-item">ü•ó Lifestyle advice</div>
                </div>
            </div>
        </div>
    </section>

    <!-- PREVENTION SECTION -->
    <section id="prevention" class="content-section">
        <div class="two-column">
            <div class="card">
                <div class="card-header safe">
                    ‚úÖ When to Offer ULT
                </div>
                <div class="card-body">
                    <p style="margin-bottom: 0.75rem; font-weight: 600;">Offer ULT (treat-to-target) if:</p>
                    <ul class="checklist safe">
                        <li>Multiple or troublesome flares</li>
                        <li>CKD stages 3-5</li>
                        <li>On diuretic therapy</li>
                        <li>Tophi present</li>
                        <li>Chronic gouty arthritis</li>
                    </ul>
                    <div class="highlight-box info" style="margin-top: 1rem;">
                        <strong>Discuss ULT option</strong> with all patients after first or subsequent flare
                    </div>
                </div>
            </div>

            <div class="card">
                <div class="card-header safe">
                    üéØ Target Serum Urate Levels
                </div>
                <div class="card-body">
                    <div style="margin-bottom: 1rem;">
                        <div class="target-value" style="margin-bottom: 0.5rem;">
                            <span>üéØ</span> Standard Target: &lt;360 ¬µmol/L
                        </div>
                    </div>
                    <div>
                        <div class="target-value secondary">
                            <span>üéØ</span> Lower Target: &lt;300 ¬µmol/L
                        </div>
                        <p style="margin-top: 0.5rem; font-size: 0.85rem; color: var(--gray-600);">For: Tophi, chronic gouty arthritis, or ongoing flares despite &lt;360</p>
                    </div>
                </div>
            </div>
        </div>

        <div class="three-column" style="margin-top: 1rem;">
            <div class="card">
                <div class="card-header info">
                    üíä Allopurinol
                </div>
                <div class="card-body">
                    <ul class="checklist">
                        <li>Start low: 100mg OD (or less)</li>
                        <li>‚Üë by 100mg every 4 weeks</li>
                        <li>Mild: 100-200mg/day</li>
                        <li>Moderate: 300-600mg/day</li>
                        <li>Severe: 700-900mg/day</li>
                    </ul>
                    <div class="highlight-box safe" style="margin-top: 0.5rem;">
                        <strong>1st line</strong> for major CVD patients
                    </div>
                </div>
            </div>

            <div class="card">
                <div class="card-header info">
                    üíä Febuxostat
                </div>
                <div class="card-body">
                    <ul class="checklist">
                        <li>Start: 80mg OD</li>
                        <li>After 2-4 weeks: if urate &gt;6mg/dL ‚Üí increase to 120mg</li>
                        <li>Check LFTs before & periodically</li>
                    </ul>
                    <div class="highlight-box urgent" style="margin-top: 0.5rem;">
                        <strong>Caution:</strong> Major CVD (use allopurinol instead)
                    </div>
                </div>
            </div>

            <div class="card">
                <div class="card-header neutral">
                    üõ°Ô∏è Flare Prophylaxis
                </div>
                <div class="card-body">
                    <p style="font-size: 0.9rem; margin-bottom: 0.5rem;">When starting/titrating ULT, offer:</p>
                    <ul class="checklist">
                        <li><strong>Colchicine</strong> 500mcg BD (1st line)</li>
                        <li>NSAID (if colchicine CI/not tolerated)</li>
                        <li>Corticosteroid (if both above fail)</li>
                    </ul>
                    <p style="font-size: 0.85rem; color: var(--gray-600); margin-top: 0.5rem;">Duration depends on flare frequency, disease duration, tophi size</p>
                </div>
            </div>
        </div>

        <div class="card" style="margin-top: 1rem;">
            <div class="card-header neutral">
                ü•ó Lifestyle Advice
            </div>
            <div class="card-body">
                <div class="two-column">
                    <ul class="checklist safe">
                        <li>Healthy, balanced diet (no specific diet proven)</li>
                        <li>Maintain healthy weight</li>
                        <li>Limit alcohol consumption</li>
                    </ul>
                    <div class="highlight-box info">
                        <strong>If flare during ULT:</strong> Treat the flare, continue ULT, reassure that flares will decrease with time
                    </div>
                </div>
            </div>
        </div>
    </section>

    <!-- PRESCRIBING SECTION -->
    <section id="drugs" class="content-section">
        <div class="drug-card">
            <div class="drug-header" onclick="toggleDrug(this)">
                <span class="drug-name">üíä Colchicine <span class="tag first-line">Acute</span> <span class="tag second-line">Prophylaxis</span></span>
                <span>‚ñº</span>
            </div>
            <div class="drug-details">
                <table class="dose-table">
                    <tr>
                        <th>Indication</th>
                        <th>Dose</th>
                    </tr>
                    <tr>
                        <td>Acute gout</td>
                        <td>500mcg 2-4√ó daily until pain relief. Max 6mg/course. Don't repeat within 3 days.</td>
                    </tr>
                    <tr>
                        <td>Prophylaxis (with ULT)</td>
                        <td>500mcg BD</td>
                    </tr>
                    <tr>
                        <td>Renal impairment</td>
                        <td>eGFR 10-50: reduce dose or increase interval. <span class="tag contraindicated">CI if eGFR &lt;10</span></td>
                    </tr>
                </table>
                <div class="highlight-box urgent" style="margin-top: 1rem;">
                    <strong>TOXICITY:</strong> Narrow therapeutic window. Overdose features: GI symptoms ‚Üí multi-organ failure. Refer immediately if suspected.
                </div>
                <div class="highlight-box urgent">
                    <strong>Key Interactions:</strong> P-gp inhibitors (macrolides, ritonavir, verapamil), CYP3A4 inhibitors, ciclosporin
                </div>
            </div>
        </div>

        <div class="drug-card">
            <div class="drug-header" onclick="toggleDrug(this)">
                <span class="drug-name">üíä Allopurinol <span class="tag first-line">ULT</span></span>
                <span>‚ñº</span>
            </div>
            <div class="drug-details">
                <table class="dose-table">
                    <tr>
                        <th>Parameter</th>
                        <th>Detail</th>
                    </tr>
                    <tr>
                        <td>Starting dose</td>
                        <td>100mg OD (or less), after food</td>
                    </tr>
                    <tr>
                        <td>Titration</td>
                        <td>Increase by 100mg every 4 weeks guided by urate level</td>
                    </tr>
                    <tr>
                        <td>Target doses</td>
                        <td>Mild: 100-200mg | Moderate: 300-600mg | Severe: 700-900mg</td>
                    </tr>
                    <tr>
                        <td>Renal impairment</td>
                        <td>Max initial 100mg, increase only if response inadequate</td>
                    </tr>
                </table>
                <div class="highlight-box urgent" style="margin-top: 1rem;">
                    <strong>HLA-B*5801:</strong> Screen Han Chinese, Thai, Korean populations before starting (SJS/TEN risk)
                </div>
                <div class="highlight-box urgent">
                    <strong>RASH:</strong> Stop immediately, seek medical advice. May be first sign of hypersensitivity.
                </div>
                <p style="margin-top: 0.75rem; font-size: 0.9rem;"><strong>Interactions:</strong> ACE inhibitors, azathioprine (reduce to ¬º dose), warfarin, thiazides</p>
            </div>
        </div>

        <div class="drug-card">
            <div class="drug-header" onclick="toggleDrug(this)">
                <span class="drug-name">üíä Febuxostat <span class="tag second-line">ULT</span></span>
                <span>‚ñº</span>
            </div>
            <div class="drug-details">
                <table class="dose-table">
                    <tr>
                        <th>Parameter</th>
                        <th>Detail</th>
                    </tr>
                    <tr>
                        <td>Starting dose</td>
                        <td>80mg OD for 2-4 weeks</td>
                    </tr>
                    <tr>
                        <td>Titration</td>
                        <td>If urate still &gt;360 ¬µmol/L, increase to 120mg OD</td>
                    </tr>
                    <tr>
                        <td>Hepatic impairment</td>
                        <td>Mild: max 80mg. Moderate-severe: limited data</td>
                    </tr>
                </table>
                <div class="highlight-box urgent" style="margin-top: 1rem;">
                    <strong>CVD CAUTION (MHRA 2023):</strong> Use with caution in major CVD (MI, stroke, unstable angina). Prefer allopurinol in these patients.
                </div>
                <p style="margin-top: 0.75rem; font-size: 0.9rem;"><strong>Monitoring:</strong> LFTs before and periodically during treatment</p>
                <p style="font-size: 0.9rem;"><strong>Interactions:</strong> Azathioprine, mercaptopurine (reduce to 20% dose), theophylline</p>
            </div>
        </div>

        <div class="drug-card">
            <div class="drug-header" onclick="toggleDrug(this)">
                <span class="drug-name">üíä NSAIDs (e.g., Naproxen) <span class="tag first-line">Acute</span></span>
                <span>‚ñº</span>
            </div>
            <div class="drug-details">
                <div class="highlight-box info">
                    <strong>Dose:</strong> Maximum dose (e.g., Naproxen 500mg BD) until 1-2 days after attack resolves
                </div>
                <ul class="checklist" style="margin-top: 1rem;">
                    <li>Consider PPI for gastric protection</li>
                    <li>CV risk: prefer ibuprofen ‚â§1200mg/day or naproxen ‚â§1000mg/day</li>
                    <li>See CKS NSAIDs - prescribing issues for full guidance</li>
                </ul>
                <div class="highlight-box urgent" style="margin-top: 0.75rem;">
                    <strong>Aspirin is NOT indicated for gout</strong>
                </div>
            </div>
        </div>

        <div class="drug-card">
            <div class="drug-header" onclick="toggleDrug(this)">
                <span class="drug-name">üíä Prednisolone <span class="tag first-line">Acute</span> <span class="tag caution">Off-label</span></span>
                <span>‚ñº</span>
            </div>
            <div class="drug-details">
                <div class="highlight-box safe">
                    <strong>Dose:</strong> 30-35mg once daily for 3-5 days
                </div>
                <p style="margin-top: 0.75rem; font-size: 0.9rem;">Alternative when NSAIDs/colchicine contraindicated or not tolerated. See CKS Corticosteroids - oral for full prescribing information.</p>
            </div>
        </div>
    </section>

    <!-- REFERRAL SECTION -->
    <section id="referral" class="content-section">
        <div class="two-column">
            <div class="card">
                <div class="card-header urgent">
                    üö® Immediate Referral
                </div>
                <div class="card-body">
                    <ul class="checklist urgent">
                        <li><strong>Septic arthritis suspected</strong> - via local care pathway</li>
                    </ul>
                </div>
            </div>

            <div class="card">
                <div class="card-header urgent">
                    ‚ö†Ô∏è Urgent Specialist Advice
                </div>
                <div class="card-body">
                    <ul class="checklist urgent">
                        <li>Suspicion of underlying systemic illness (e.g., RA, CTD)</li>
                        <li>Gout in pregnancy</li>
                        <li>Gout in young person (&lt;30 years)</li>
                        <li>IA steroid needed but expertise unavailable</li>
                        <li>Complications present</li>
                        <li>Risk of adverse drug effects</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class="card" style="margin-top: 1rem;">
            <div class="card-header info">
                üè• Consider Rheumatology Referral
            </div>
            <div class="card-body">
                <ul class="checklist info">
                    <li>Diagnosis uncertain</li>
                    <li>Inadequate response to treatment</li>
                    <li>Treatment not tolerated</li>
                    <li>Treatment contraindicated</li>
                    <li>CKD stages 3b-5 (eGFR &lt;45)</li>
                    <li>Organ transplant recipient</li>
                </ul>
            </div>
        </div>

        <div class="card" style="margin-top: 1rem;">
            <div class="card-header neutral">
                üìä Comorbidity Screening
            </div>
            <div class="card-body">
                <p style="margin-bottom: 0.75rem;">Screen at least annually:</p>
                <div class="criteria-grid">
                    <div class="criteria-item">ü´ò eGFR & ACR (for CKD)</div>
                    <div class="criteria-item">‚ù§Ô∏è CV risk factors</div>
                    <div class="criteria-item">üìà BP & lipids</div>
                    <div class="criteria-item">üç¨ Glucose (diabetes)</div>
                </div>
                <div class="highlight-box info" style="margin-top: 1rem;">
                    <strong>Note:</strong> ~25% of gout patients have CKD stages 3-5. MI prevalence 2.8%, HTN 63.9%.
                </div>
            </div>
        </div>
    </section>

    <footer class="footer">
        <p><strong>Source:</strong> NICE Clinical Knowledge Summaries - Gout | Last revised June 2023</p>
        <p style="margin-top: 0.5rem;">For full prescribing information, 